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Surgical site infection: the size of the problem and strategies to prevent them 
Jennie Wilson 
Summary  
Surgical site infections (SSI) are an important cause of healthcare associated infection (HCAI) and are 
associated with considerable morbidity and mortality. Although intrinsic factors in the patient, such 
as age, underlying illness and site of the procedure increase the risk, the quality of care delivered 
during the perioperative period is critical to preventing SSI.  This paper explores what is known 
about the epidemiology and pathogenesis, and practices that are effective in reducing the risk of SSI.   
The epidemiology and pathogenesis of SSI 
Surgical site infections are an important cause of HCAI. In the most recent prevalence survey 
undertaken in the UK, they were the third most common type of HCAI after pneumonia and UTI and 
accounted for 15% of all infections (PHE 2012) (Figure 1).  These results will underestimate the true 
burden, as for many types of surgery the length of time the patient spends in hospital after the 
procedure is very short and the patient will have already been discharged home before the SSI has 
become apparent.  In addition, only those patients in hospital who undergo surgery can acquire an 
SSI, and for this subset of patients it is the most common HCAI they are at risk of and the prevalence 
of SSI in this group is estimated as at least 5% (Smythe et al 2006).  
Surgical site infections can affect only the superficial subcutaneous layers of skin or, less commonly, 
involve the muscle and fascial layers (or deep SSI) or even affect the organs and other sites 
manipulated during the operation, (these are called organ/space SSI) (PHE 2011).  Most SSI will be 
acquired during the operative procedure as once the wound is closed the surface of the skin seals 
rapidly and is protected from infection unless an external drain is present.  The three main sources 
of pathogens that cause SSI are: 
 Microbial flora on the skin and in the body of the patient 
 Microbial flora (skin or mucous membranes) of operating personnel 
 The operating room environment that includes airborne particles, instruments and tools 
used during the procedure.  
 
Occasionally, micro-organisms released into the blood stream from a distant infection at another 
site in the body e.g. urinary tract, can establish an SSI after the procedure by attaching to a 
prosthesis or other implant left in the operative site (David & Vrahas, 2000). 
 
Risk factors for SSI 
However, the risk that a patient will develop an infection depends on a combination of factors which 
influence how many micro-organisms are introduced into the operative site, the number that remain 
when the wound is closed, the ability of the micro-organisms to multiply and invade tissues in the 
operative site, and the efficacy of the host’s immune defences against them (NICE, 2008a).  The site 
of the body where the operation is performed is a key factor as this determines the number of 
microorganisms already present and available to establish infection.  Thus, the risk of SSI is much 
greater for procedures on the intestines, which are already heavily colonised with bacteria, than 
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those performed on bone where the tissue is sterile. Figure 1 illustrates the risk of SSI associated 
with different types of surgery and is derived from data collected as part of the national SSI 
surveillance system in England. This shows that in large bowel surgery an SSI is detected in 10% of 
patients whilst in orthopaedic surgery such as hip replacement an SSI is identified in only 0.7%  
(Table 1).  This difference in risk of microbial contamination is often described by a wound 
classification system which distinguishes clean wounds from those that involve a body tract (clean-
contaminated), have increased contamination due to traumatic injury, gastrointestinal spillage or 
pre-existing infection (contaminated or dirty) (PHE 2011).  Other factors intrinsic to the patient also 
influence the risk that they subsequently develop an SSI.  Age is once of the most important factors, 
with many studies demonstrating that the risk of SSI steadily increases with age across different 
types of surgery (NICE 2008a, Mu et al 2011, PHE 2014).  A study on risk factors for SSI following hip 
replacement demonstrated that patients over 75 years were more than 1.5 times more likely to 
develop SSI than those under 65 years (Ridgway et al 2005).  Underlying illnesses also have a very 
important effect on the risk of SSI and a simple way of measuring this is by the ASA score (American 
Society of Anesthesiologist classification of physical status score).  A score of 3 or more indicates that 
patients have a severe underlying disease process and this group are consistently shown to have a 
significantly higher risk of SSI than those with a score of 1 or 2 (Mu et al 2011, PHE 2014, Ridgeway 
et al 2005, NICE 2008a).  Whilst other specific conditions such as diabetes also significantly increase 
the risk of SSI (Zhang et al 2015), the presence of these underlying conditions is also captured in the 
increased ASA score. 
Morbidity and mortality associated with SSI 
Surgical site infections are associated with considerable morbidity and mortality.  The most common 
measure of adverse effect is the impact on length of hospital stay.  In the UK, Coello et al (2005) 
analysed a large set of data captured as part of the national SSI surveillance system and compared 
the length of stay for those patient who developed an SSI with those that did not.  This 
demonstrated that an SSI, regardless of whether it was superficial or more severe, doubled the 
length of post-operative hospital stay with attributable increased costs of between £1000 and £6000 
per SSI depending on the type of surgery. Other studies have confirmed the effect of SSI on length of 
hospital stay and significant impact on costs (Jenks et al 2014) and also accounted for additional 
post-discharge costs. For example, a case control study of patients undergoing proximal femoral 
fracture repair, found that when repeat admissions to hospital, re-operations and other treatments 
are taken into account, severe SSI can quadruple the costs of care and decrease the quality of life of 
affected patients (Whitehouse et al, 2002).   
 
SSI has an important, but often overlooked impact on mortality with a case fatality rate of 4.5% and 
38% of these deaths being directly attributable to SSI (Astagneau et al, 2001).  Coello et al 2005 
found a significant increase in in-hospital mortality associated with deep or organ-space SSI for three 
major categories of surgery: hip prosthesis (OR 2.5; 95%CL 1.3-4.5), large bowel surgery (OR 1.8; 
95%CL 1.1-3.2) and vascular surgery (OR 6.8; 95%CL 3.0-15.4). 
 
Evidence for practice to prevent SSI 
Whilst it may be difficult to affect the intrinsic risk of SSI perioperative practice is critical to reduce 
the extrinsic risk and is aimed at minimising the number of micro-organisms introduced into the 
operative site.  This includes practices directed at removing micro-organisms that normally colonise 
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the skin prior to making the incision; preventing the introduction and multiplication of micro-
organisms at the operative site; enhancing the patients’ defences against infection; and preventing 
access of micro-organisms into the incision postoperatively (NICE, 2008a, Wilson 2013a).  ‘Custom 
and practice’ dominates theatre procedures and whilst huge emphasis is often placed on ritualistic 
practices, many of them are not underpinned on any robust evidence to demonstrate their efficacy 
in terms of prevention of SSI (Woodhead et al 2002).  Some key aspects of practice to prevent SSI are 
outlined below. 
 
Minimising airborne contamination 
Airborne bacteria are considered to be the most important route by which microorganisms enter a 
wound during an operation (Chow & Yang 2004).  The main source of airborne particles are theatre 
personnel who continuously shed skin scales and fabric lint from their clothing, with the number of 
particles released increased by movement and the number of people present. These particles can 
enter the operative site by either falling directly into the wound or by first settling onto exposed 
instruments equipment or surgeons hands and then being carried into the wound (Hoffman et al 
2002).  Theatre ventilation systems are intended to prevent airborne particles carrying micro-
organisms from entering the surgical wound.  This is achieved by filtering out particles from the 
supplied air, diluting contaminated air in the theatre (by changing the air volume in the room at least 
25 times per hour) and by preventing the entry of contaminated air from outside the theatres. The 
flow of air is directed to ensure that it moves from the cleanest (room used to lay-up instruments 
and then the operating theatre itself) to the dirtiest areas (disposal room and corridors). This is 
achieved by creating pressure differentials, supplying air at a greater rate to clean areas and 
extracting it from the disposal room (Hoffman et al 2002, Department of Health 2007).  Ultra clean 
air (UCA) systems are often used for orthopaedic procedures where microbial contamination of the 
joint and subsequent SSI can have devastating effects.  These use filtered linear airflow at high 
pressure to reduce the concentration of airborne bacteria directly over the operative site, although 
the reduction in contamination can be highly variable depending on local configuration and factors 
that might deflect the air flow (Chow & Yang 2004).  A multicentre randomised controlled trial in the 
1980s demonstrated a more than two-fold reduction in risk of deep sepsis following hip and knee 
replacement associated with UCA (Lidwell et al 1982).  However, this study did not control for risk 
factors, or the use of prophylactic antibiotics, which also appeared to have a significant protective 
effect.  Although the use of UCA for orthopaedic surgery is strongly supported in the UK, it is not 
considered a requirement in other countries (Miner et al 2005). Recent studies suggest that UCA 
actually increases rather than reduces the risk of SSI in orthopaedic surgery and their use is not cost-
effective (Hooper et al 2011; Zheng et al 2014).   
 
Whilst theatre ventilation systems contribute to eliminating airborne particles, theatre staff have a 
key role to play in minimising the amount of contaminated airborne particles introduced to the 
wound.  Several aspects of ‘theatre discipline’ are key to this, including ensuring that instruments 
layed up in a clean area as close to the start of surgery as possible, that equipment brought into 
theatre is cleaned and free from dust, and restricting the number of people present in the theatre, 
and movement in and out of theatre to a minimum from the time instrument lay up start to when 
the wound is closed.  A recent study by Agodi et al (2015) demonstrated that high levels of airborne 
bacterial contamination in operating theatres occurred during most procedures (even when UCA 
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was used), and these were correlated with the number of personnel present in the operating room 
and the number of times the doors were opened.   
 
Preparation of the patients’ skin  
The patients’ skin is an important source of microbial flora that could cause SSI including both 
transient microorganisms acquired by touch that are easily removed by washing with soap, and 
resident flora that normally live in the skin, are not removed by washing with soap but can be 
reduced by antiseptics.  Patients should therefore shower prior to a procedure and there is some 
evidence that this reduces the risk of SSI (NICE 2008a, NICE 2013, Kamel et al 2012).  The presence of 
hair at the operative site does not increase the risk of SSI and removing it can increase the risk of 
infection by causing micro-abrasions of the skin that harbor microorganisms.  Hair at the operative 
site should therefore not be routinely removed, and if removal is necessary in order to visualise the 
site, it should be removed on the day of the procedure using hair clippers (NICE 2008a, NICE 2013).  
Antiseptic solutions, formulated using iodine or chlorhexidine, are recommended for preparation of 
the incision site in order to remove resident flora (NICE 2008a). There is some evidence that alcohol-
based solutions are more effective in preventing SSI and that 2% chlorhexidine-alcohol is superior to 
povidone-iodine (NICE 2013, Dumville 2012, Dariouche 2010).  Skin preparation solutions are best 
delivered as single-use items, as there are risks of both contamination and misuse associated with 
multi-use containers (NHS England 2015, Woodhead 2002).  
 
Theatre personnel and clothing 
Clothing worn by theatre staff is designed to minimise the transfer of micro-organisms from the skin 
or mucous membranes into the wound but in addition to protect the surgical team from exposure to 
blood and body fluids (HSE 2013). Closely woven materials such as disposable gowns and drapes 
minimise the extent to which micro-organisms are dispersed from the skin of the wearer (Woodhead 
et al 2002, Al-Hashemi et al 2013).   
 
Surgical masks are often the source of considerable controversy, however, their primary purpose is 
to prevent blood or body fluid contaminating the mucous membranes of the wearer’s nose and 
mouth. They do not protect against inhalation of airborne particles and are not classified as 
respiratory protective equipment; specialist respirator masks are required to offer protection against 
inhalation of aerosols e.g. laser plume (Coia et al 2013). The risk of micro-organisms from the 
respiratory tract of staff entering the operative site is minimal and a recent systematic review of 
randomised and quasi randomised controlled trials comparing rates of SSI with and without the use 
of surgical masks found no evidence that they reduce the risk of SSI (Lipp & Edwards 2012, NICE 
2013).  
 
The resident flora on hands could be transferred into the wound, therefore the surgical team 
prepare their hands with an antiseptic solution prior to donning sterile gowns and gloves in order to 
remove this resident flora. Alcohol-based antiseptic solutions are particularly effective and 
chlorhexidine has the advantage of persisting on the skin over prolonged periods (WHO 2009).  The 
use of two pairs of gloves significantly reduces the number of gloves perforations to the inner glove 
and double-gloving has been associated with a reduced risk of SSI (Tanner & Parkinson 2006, Mistelli 




An important adverse effect of anaesthesia is hypothermia due to vasodilation and loss of body 
responses to thermoregulation.  Evidence suggests that inadvertently reducing the body 
temperature below 36oC during the operation is associated with increased intraoperative blood loss, 
morbid cardiac events and SSI (NICE 2008b). Maintaining normothermia perioperatively is therefore 
recommended in order to minimise these adverse effects. This requires that all patients who 
undergo a procedure lasting longer than 30 minutes should be actively warmed and those at 
particular risk of developing hypothermia should be identified so that warming can be commenced 
prior to transfer to theatre.  In addition, the patients temperature should be monitored throughout 
the procedure and in recovery and maintained above 36oC throughout the perioperative period and 
both IV and intra-cavity fluids warmed before use (NICE 2008b).  Active warming may be achieved 
through use of devices that deliver forced air or conductive heat. Although some concerns have 
been raised about an increase in airborne particles when forced air warming is used in combination 
with UCA (Wood et al 2014), the majority of studies have significant methodological flaws and no 
convincing evidence of an increased risk of SSI (Kellam et al 2013).  
 
Surveillance of rates of SSI 
Surveillance is defined as the systematic capture, reporting and dissemination of data on rates of 
infection and evidence for its impact on reducing rates of SSI was first published in the 1970s and 
comprehensively demonstrated by a large study conducted by the Centers for Disease Control in the 
USA (Cruse and Foord 1973, Haley et al 1980, Wilson 2013a).  Rates of SSI were found to be up to 
38% lower in hospitals that conducted comprehensive SSI surveillance including feedback of rates to 
the surgical team and involvement of an epidemiologist in generating and interpreting the rates 
(Haley et al 1980).  National systems that enable hospitals to benchmark their rates against a 
national average have also been found to be associated with significant reductions in rates of SSI 
(Gastmeier et al 2005; Rioux et al 2007).   However, in the UK participation in surveillance of SSI is 
largely focused on mandatory requirements, which in England are focused only on orthopaedic 
surgery.  This means that for the majority of surgical procedures performed there is no data 
captured to inform either the patient or the surgical team about the risk of SSI or quality of practice 
to prevent infection.  In addition, the length of post-operative stay is now short for many procedures 
and therefore robust but cost-effective systems that can measure SSI that occur after discharge are 
required to more accurately measure and take action in response to rates of SSI (Wilson et al 2013a).  
The results of surveillance indicate that there is considerable variation in rates of SSI between 
hospitals and whilst some of this may be explained by differences in case-mix, it also points to 
differences in quality of care that affect the risk of SSI (Wilson 2013b).  Involving theatre staff in the 
feedback of data on rates of SSI is essential if they are to use the information to drive improvements 
in practice.  
 
Conclusions 
The impact of delivering high quality care in operating theatres that is directed at prevention of SSI is 
signposted by a study conducted in the USA on 117 hospitals contributing data to a national system 
conducting surveillance on post-operative complications (Campbell et al 2008). This showed that 
those hospitals with low rates of SSI were more likely to have efficient systems that achieved 15% 
shorter operation times and policies on minimising traffic in the operating room, but also a positive 
safety culture, strong leadership for quality improvement, and environment that fostered 
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communication.  A recent initiative started in the UK called OneTogether has brought together key 
professional groups including the Infection Prevention Society, Association of Perioperative 
Practitioner, College of Operating Department Practitioners and Royal College of Nursing in 
collaboration with 3M Healthcare, with the aim of supporting the implementation of best practice to 
prevent SSI (Wilson et al 2015).  The work of this partnership has demonstrated how staff have 
difficulties in translating evidence-based guidance into everyday practice, with a lack of local policies 
and poor compliance with some aspects of gudiance fuelled by lack of information or training, 
leadership and ownership (Wilson et al 2015).  This highlights the clear need for an increased focus 
on delivering high quality care in operating theatres and OneTogether will be working to support this 
through the development of readily accessible resources to inform and educate staff working across 
the entire surgical pathway.  
 
Dr Jennie Wilson is an Associate Professor in Healthcare Epidemiology at the Richard Wells Research Centre at 
the University of West London. She has 30 years of experience in infection control, established and led the 
Surgical Site Infection Surveillance Service at Public Health England for 10 years, and is author of evidence-
based guidelines on infection control and surgical site infection.   
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Figure 1: The frequency distribution of the six most common healthcare associated infections 






















Table 1: Incidence of surgical site infection by surgical category 
Source: Public Health England (2014) 
Based on data captured by the Surgical Site Infection Surveillance Service in England between April 2009 and 
March 2014. 
Category of procedure No. operations No. SSI* % infected 
Abdominal hysterectomy 4512 65 1.4% 
Breast surgery 7634 71 0.9% 
Cholecystectomy 957 45 4.7% 
Coronary artery bypass graft 30,838 1400 4.5% 
Cardiac surgery 9465 116 1.2% 
Cranial surgery 4963 72 1.5% 
Hip prosthesis 180,852 1246 0.7% 
Knee prosthesis 188,974 1145 0.5% 
Large bowel surgery 17,924 1824 10.2% 
Small bowel surgery 4105 275 6.7% 
Spinal surgery 33.053 378 1.1% 
Vascular surgery 7249 204 2.8% 
* Includes SSI detected during the inpatient stay or on readmission to hospital 
  
